Leg Muscle Activity and Heart Rate in Different Body Positions in Children With Cerebral Palsy
NCT07932015, Active not recruiting, Klaipėda University
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Leg Muscle Activity and Heart Rate in Different Body Positions in Children With Cerebral Palsy | ClinicalTrials.gov |
| NCT number | NCT07932015 | ClinicalTrials.gov |
| Status | Active not recruiting | ClinicalTrials.gov |
| Enrollment | 6 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Klaipėda University | ClinicalTrials.gov |
| Conditions | Cerebral Palsy | ClinicalTrials.gov |
| Interventions | Routine Care Positioning | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Lower-Limb Surface Electromyography RMS Amplitude During Supported Standing | During one supported-standing session lasting up to 20 minutes, approximately two weeks after the first measurement visit. | Surface electromyography root mean square (RMS) amplitude, expressed in microvolts (µV), calculated over the entire recorded supported-standing period. Measurements are obtained bilaterally from the rectus femoris, biceps femoris, gluteus maximus, and lateral head of the gastrocnemius using the Biometrics DataLINK system. Values are reported separately for each muscle and side, without normalization. This outcome is assessed only in participants undergoing supported standing as part of routine care. | ClinicalTrials.gov |
| Secondary | Mean Heart Rate in Different Body Positions | During 20-minute lying and sitting recordings and up to 20 minutes of supported standing, across approximately two weeks. | Mean heart rate, expressed in beats per minute, calculated over the entire recording in each position. All participants are assessed while lying and sitting. Participants able to undergo supported standing are additionally assessed while standing. Recordings are obtained using a Polar H10 sensor on separate days at weekly intervals, in the morning before breakfast. | ClinicalTrials.gov |
| Secondary | Duration of Supported Standing | During one supported-standing session lasting up to 20 minutes, approximately two weeks after the first measurement visit. | Actual supported-standing duration, expressed in minutes, up to a planned maximum of 20 minutes. Assessed only in participants undergoing supported standing. Reasons for early termination are documented in free-text notes. | ClinicalTrials.gov |
| Secondary | Time to First Observed Sign of Discomfort During Supported Standing | During one supported-standing session lasting up to 20 minutes, approximately two weeks after the first measurement visit. | Time in minutes from the start of supported standing to the first observed sign of discomfort, such as crying, restlessness, or pain-related behavior, documented in observational notes. If no signs occur, this is recorded as no discomfort observed during the actual session; the session end is not treated as a discomfort event. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 3
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)